Psychedelics field looks ahead after FDA advisers’ rejection

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Psychedelics’ Use as Medicine Hits Significant Roadblock2024
2. 2What’s next for psychedelics after MDMA rejection?2024 · 10 citations
3. 3Reaction mixed over FDA committee rejection of MDMA therapy for PTSD2024
4. 4Much anticipated FDA decision about psychedelics for PTSD ends with denial2024
5. 5FDA publicly releases MDMA rejection letter; MAPS vows to press forward2025